ReviewGenes2022
Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.
Gunjan Thakur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewGenes2022
Gunjan Thakur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.